ROSEN, LEADING INVESTOR COUNSEL, Encourages bluebird bio Inc. Investors to Inquire About Securities Class Action Investigation – BLUE – bluebird bio (NASDAQ:BLUE)
Rosen Law Firm, a global investor rights law firm, is actively investigating potential securities claims on behalf of shareholders of bluebird bio Inc. (NASDAQ:BLUE). These investigations are in response to allegations suggesting that bluebird may have provided the public with materially misleading business information.
If you have invested in bluebird securities, this could be significant for you. You might be entitled to compensation without the need to pay any out-of-pocket fees or costs through a contingency fee arrangement. Rosen Law Firm is currently preparing a class action lawsuit to seek recovery of investor losses tied to this issue.
Important Information for bluebird bio Investors
Upon discovery of potentially materially misstated financial documents, bluebird bio made a critical filing with the Securities and Exchange Commission (SEC). On March 26, 2024, before market hours, bluebird submitted an 8-K filing, revealing that based on management’s recommendation and after consultations with their auditor, EY, it was determined that the company’s audited consolidated financial statements for the fiscal years starting January 1, 2019, and the unaudited interim condensed consolidated financial statements for the first three quarters of these years, along with associated earnings releases and communications, were materially misstated and should no longer be relied upon.
This revelation had a significant impact on bluebird’s stock price, which fell $0.16 per share, or 11.8%, closing at $1.20 per share on March 26, 2024. This significant drop underscores the importance of accurate financial reporting and the potential consequences of discrepancies.
Why Rosen Law Firm?
Choosing the right counsel is crucial for investors seeking to recover losses. Rosen Law Firm stands out with a proven track record of success in leadership roles in significant securities class actions. The firm not only represents investors worldwide but has also secured the largest ever securities class action settlement against a Chinese Company. Further illustrating its prowess, Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for the number of securities class action settlements in 2017 and has consistently been ranked in the top 4 each year since 2013. The firm’s accomplishments include recovering hundreds of millions of dollars for investors, with over $438 million secured in 2019 alone. Founding partner Laurence Rosen’s recognition by law360 as a Titan of Plaintiffs’ Bar in 2020 highlights the firm’s legal excellence and commitment to its clients.
For investors in bluebird bio Inc., taking action could not only contribute to the recovery of personal losses but also signal to the market the importance of transparency and accountability in financial reporting. If you have been affected and wish to join the class action, considering the expertise and accomplishments of your legal representation is paramount.
